A new test for detecting gonorrhea using advanced technology.
Ultrasensitive Point of Care Antigen Test for Detection of Neisseria Gonorrhoeae Using Plasmonic Flours
This study is working on a quick and easy test for gonorrhea that can give accurate results right where you are, using urine samples, so it’s especially helpful for people in places where regular testing isn’t available.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10891640 on NIH RePORTER |
What this research studies
This research aims to develop a highly sensitive and rapid antigen test for Neisseria gonorrhoeae, the bacteria responsible for gonorrhea. By utilizing innovative plasmonic-fluors technology, the test seeks to provide accurate results at the point-of-care, making it accessible even in resource-limited settings. The study will involve optimizing the test for urine samples and comparing its accuracy against the current gold standard tests. This approach could significantly improve the diagnosis of gonorrhea, especially in areas where traditional testing methods are not feasible.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are suspected of having a gonorrhea infection and can provide urine samples for testing.
Not a fit: Patients who have already been diagnosed and treated for gonorrhea may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more accurate and accessible method for diagnosing gonorrhea, improving patient outcomes and public health responses.
How similar studies have performed: Other research has shown promise in developing rapid diagnostic tests for sexually transmitted infections, but this specific approach using plasmonic-fluors is novel.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Gandra, Sumanth — Washington University
- Study coordinator: Gandra, Sumanth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.